Latest News for Abeona Therapeutics Stock (NASDAQ:ABEO)

Monday, November 27, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - 6 days ago
Abeona Therapeutics shares are trading higher after the company announced the FDA accepted and granted Priority Review for the Biologics License Application for pz-cel.
Benzinga Newsdesk - 6 days ago
Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
Benzinga Newsdesk - 6 days ago

Monday, November 13, 2023

Recap: Abeona Therapeutics Q3 Earnings
Benzinga Insights - Nov 13, 2023, 7:40AM

Friday, September 29, 2023

Abeona Therapeutics Insider Trades Send a Signal
Benzinga Insights - Sep 29, 2023, 11:01AM

Tuesday, September 26, 2023

Abeona Therapeutics Has Submitted A Biologics License Application To The FDA Seeking Approval Of EB-101 For Recessive Dystrophic Epidermolysis Bullosa
Benzinga Newsdesk - Sep 26, 2023, 7:40AM

Wednesday, August 30, 2023

Abeona Therapeutics Announces Positive Pre-BLA Meeting With FDA for EB-101 And Plans For BLA Submission
Benzinga Newsdesk - Aug 30, 2023, 7:33AM

Thursday, August 24, 2023

Cantor Fitzgerald Reiterates Overweight on Abeona Therapeutics, Maintains $38 Price Target
Benzinga Newsdesk - Aug 24, 2023, 11:49AM

Tuesday, August 08, 2023

Abeona Therapeutics' Cash On Hand Of $37.1M Plus Proceeds From Registered Direct Offering Of $25M Is Projected To Fund Operations Into Q4 Of 2024
Benzinga Newsdesk - Aug 8, 2023, 7:47AM
Abeona Therapeutics Q2 EPS $(0.92) Up From $(1.36) YoY
Benzinga Newsdesk - Aug 8, 2023, 7:46AM

Wednesday, August 02, 2023

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Aug 2, 2023, 9:06AM

Friday, July 28, 2023

Abeona Therapeutics Has Submitted The Briefing Package To The FDA For Its Pre-biologics License Application Meeting In August 2023 Regarding The Application For EB-101, Engineered Cell Therapy For Recessive Dystrophic Epidermolysis Bullosa
Benzinga Newsdesk - Jul 28, 2023, 7:38AM

Thursday, July 13, 2023

Cantor Fitzgerald Reiterates Overweight on Abeona Therapeutics, Maintains $38 Price Target
Benzinga Newsdesk - Jul 13, 2023, 8:56AM

Monday, July 03, 2023

Abeona Therapeutics Announces $25M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Benzinga Newsdesk - Jul 3, 2023, 8:46AM

Friday, June 09, 2023

Abeona Therapeutics Announced Regulatory Update On Biologics License Application For EB-101; Said FDA Requested Additional Assay Data To Establish Comparability Between RVV Sourced From Indiana University, RVV Manufactured In-house At Abeona
Charles Gross - Jun 9, 2023, 7:34AM

Wednesday, May 24, 2023

Alliance Global Partners Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target
Benzinga Newsdesk - May 24, 2023, 11:58AM

Thursday, May 11, 2023

Recap: Abeona Therapeutics Q1 Earnings
Benzinga Insights - May 11, 2023, 8:45AM
Abeona Therapeutics Q1 EPS $(0.54) Beats $(0.61) Estimate; Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $40.7M Are Sufficient Resources To Fund Operations Into Q3 Of 2024
Benzinga Newsdesk - May 11, 2023, 7:47AM

Tuesday, April 18, 2023

Watching Abeona Therapeutics; Zacks Small-Cap Research Sets $10 Price Valuation
Happy Mohamed - Apr 18, 2023, 11:00AM

Wednesday, March 29, 2023

Abeona Therapeutics Reports 2022 Net Loss Attributable $(43.5)M Or $(5.53) Per Share Vs $(84.9)M Or $(21.57) Per Share Last Year
Benzinga Newsdesk - Mar 29, 2023, 7:38AM

Thursday, March 16, 2023

Abeona Therapeutics Announces Acceptance Of Abstract On EB-101 Phase 3 VIITAL Study Results For Oral Presentation At International Societies For Investigative Dermatology 2023 Meeting
Benzinga Newsdesk - Mar 16, 2023, 7:33AM

Monday, February 13, 2023

Abeona Therapeutics-Sponsored Trial: EB-101 Treatment for New and Previously Treated Patients With Recessive Dystrophic Epidermolysis Bullosa Posted To Clinical Trials Website; Study Not Yet Recruiting
Charles Gross - Feb 13, 2023, 11:10AM

Monday, November 21, 2022

PaxMedica, Getty Images And 3 Short Squeeze Candidates That Could Soar This Week
Chris Katje - Nov 21, 2022, 12:02PM

Monday, November 14, 2022

SVB Leerink Maintains Market Perform on Abeona Therapeutics, Raises Price Target to $6
Benzinga Newsdesk - Nov 14, 2022, 1:42PM
Abeona Therapeutics Q3 EPS $(1.48) Up From $(3.50) YoY
Bill Haddad - Nov 14, 2022, 7:40AM

Tuesday, November 08, 2022

Cantor Bullish On Abeona Saying Recent Trial Data 'Best Case Scenario'
Vandana Singh - Nov 8, 2022, 2:28PM
Cantor Fitzgerald Maintains Overweight on Abeona Therapeutics, Raises Price Target to $40
Benzinga Newsdesk - Nov 8, 2022, 11:32AM

Thursday, November 03, 2022

Abeona Therapeutics shares are trading lower after the company announced a $35 million private placement financing agreement.
Benzinga Newsdesk - Nov 3, 2022, 2:39PM
Abeona Therapeutics Touts Positive Data From Pivotal EB-101 Study In Blistering Skin Disorder
Vandana Singh - Nov 3, 2022, 12:44PM
Abeona Therapeutics Announces $35M Private Placement Financing
Benzinga Newsdesk - Nov 3, 2022, 7:55AM
Abeona Therapeutics Announces Phase 3 VIITAL Study Met Two Co-Primary Efficacy Endpoints
Benzinga Newsdesk - Nov 3, 2022, 7:39AM

Wednesday, October 19, 2022

Abeona Therapeutics Announces Database Lock For Pivotal Phase 3 VIITAL Study Of EB-101 In Patients With Recessive Dystrophic Epidermolysis Bullosa
Benzinga Newsdesk - Oct 19, 2022, 7:32AM

Monday, October 17, 2022

Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
Lisa Levin - Oct 17, 2022, 5:21AM

Monday, October 10, 2022

Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
Lisa Levin - Oct 10, 2022, 5:28AM

Friday, October 07, 2022

How Is The Market Feeling About Abeona Therapeutics?
Benzinga Insights - Oct 7, 2022, 3:25PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Oct 7, 2022, 2:26PM
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session
Lisa Levin - Oct 7, 2022, 12:27PM

Tuesday, October 04, 2022

Abeona Therapeutics Announces Completion Of Patient Follow-Up In Pivotal Phase 3 VIITAL Study Ff EB-101
Bill Haddad - Oct 4, 2022, 7:36AM

Thursday, August 11, 2022

SVB Leerink Maintains Market Perform on Abeona Therapeutics, Raises Price Target to $5
Benzinga Newsdesk - Aug 11, 2022, 1:59PM
Abeona Therapeutics shares are trading higher after the company reported Q2 EPS results were up year over year.
Benzinga Newsdesk - Aug 11, 2022, 1:44PM
Recap: Abeona Therapeutics Q2 Earnings
Benzinga Insights - Aug 11, 2022, 9:42AM
Abeona Therapeutics Q2 EPS $(2.08) Up From $(4.00) YoY
Benzinga Newsdesk - Aug 11, 2022, 7:42AM

Thursday, August 04, 2022

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Aug 4, 2022, 8:18AM

Wednesday, July 20, 2022

Abeona Therapeutics Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Jul 20, 2022, 7:34AM

Monday, July 11, 2022

Tesla, Twitter And 76 Biggest Movers From Friday
Lisa Levin - Jul 11, 2022, 7:30AM

Friday, July 08, 2022

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
Lisa Levin - Jul 8, 2022, 4:15AM

Tuesday, July 05, 2022

The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study
Vandana Singh - Jul 5, 2022, 9:07AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 5, 2022, 8:12AM
Abeona Therapeutics Shares Trading Following Effect of 1:25 Reverse Stock Split
Charles Gross - Jul 5, 2022, 6:13AM

Thursday, June 30, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights - Jun 30, 2022, 5:41PM

Open-	Close-
Vol / Avg.0 / 138.219K	Mkt Cap119.655M
Day Range- - -	52 Wk Range2.190 - 5.400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Abeona Therapeutics Stock (NASDAQ:ABEO)

Monday, November 27, 2023

Monday, November 13, 2023

Friday, September 29, 2023

Tuesday, September 26, 2023

Wednesday, August 30, 2023

Thursday, August 24, 2023

Tuesday, August 08, 2023

Wednesday, August 02, 2023

Friday, July 28, 2023

Thursday, July 13, 2023

Monday, July 03, 2023

Friday, June 09, 2023

Wednesday, May 24, 2023

Thursday, May 11, 2023

Tuesday, April 18, 2023

Wednesday, March 29, 2023

Thursday, March 16, 2023

Monday, February 13, 2023

Monday, November 21, 2022

Monday, November 14, 2022

Tuesday, November 08, 2022

Thursday, November 03, 2022

Wednesday, October 19, 2022

Monday, October 17, 2022

Monday, October 10, 2022

Friday, October 07, 2022

Tuesday, October 04, 2022

Thursday, August 11, 2022

Thursday, August 04, 2022

Wednesday, July 20, 2022

Monday, July 11, 2022

Friday, July 08, 2022

Tuesday, July 05, 2022

Thursday, June 30, 2022